Brief: Adial Pharmaceuticals Provides Business Update And Reports First Quarter 2022 Financial Results
Adial Pharmaceuticals Inc ADIL.O :
* ADIAL PHARMACEUTICALS PROVIDES BUSINESS UPDATE AND REPORTS
FIRST
QUARTER 2022 FINANCIAL RESULTS
* Q1 LOSS PER SHARE $0.13
* ENDED Q1 WITH CASH AND CASH EQUIVALENTS OF $12.7 MILLION
Source text for Eikon: ID:nGNX3FTLJp
Further company coverage: ADIL.O
Recent news on Adial Pharmaceuticals
See all newsBrief: Adial Pharmaceuticals Announces Name Change To Azora Therapeutics
Brief: Adial Pharmaceuticals Announces Planned Appointment Of Celia Economides As Chief Financial Officer
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Adial Pharmaceuticals - Proposed Resale Of Up To 25,148,970 Shares Of Common Stock By Selling Stockholders - SEC Filing
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)